Table 3

Response rate (CR + PR) according to the Camitta criteria

Newly diagnosed (n = 107)
Previously treated (n = 103)
6pLOH(−) (n = 91), no. (%)6pLOH(+) (n = 16), no. (%)6pLOH(−) (n = 88), no. (%)6pLOH(+) (n = 15), no. (%)
Immunosuppressive therapies (all) 36/49 (73) 11/11 (100) 65/77 (84) 12/12 (100) 
    ATG + CsA 14/19 (74) 7/7 (100) 27/33 (82) 5/5 (100) 
    CsA alone 22/30 (73) 4/4 (100) 38/44 (86) 7/7 (100) 
Anabolic steroid alone 0/0 (0) 0/0 (0) 7/11 (64) 2/2 (100) 
Unknown/not evaluable 42 
Newly diagnosed (n = 107)
Previously treated (n = 103)
6pLOH(−) (n = 91), no. (%)6pLOH(+) (n = 16), no. (%)6pLOH(−) (n = 88), no. (%)6pLOH(+) (n = 15), no. (%)
Immunosuppressive therapies (all) 36/49 (73) 11/11 (100) 65/77 (84) 12/12 (100) 
    ATG + CsA 14/19 (74) 7/7 (100) 27/33 (82) 5/5 (100) 
    CsA alone 22/30 (73) 4/4 (100) 38/44 (86) 7/7 (100) 
Anabolic steroid alone 0/0 (0) 0/0 (0) 7/11 (64) 2/2 (100) 
Unknown/not evaluable 42 

CR indicates complete remission; PR, partial remission; ATG, antithymocyte globulin; and CsA, cyclosporine A.

or Create an Account

Close Modal
Close Modal